Famodar | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Famodar
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Famodar

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

92 API Suppliers, 24 USDMF, 17 CEP/COS, 13 JDMF, 17 EU WC, 34 KDMF, 25 NDC API, 37 Listed Suppliers, $ API Reference Price

92 API Suppliers
24 USDMF
17 CEP/COS
13 JDMF
17 EU WC
34 KDMF
25 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

61 Drugs in Development

61 Drugs in Development

INTERMEDIATES

16 Intermediate Suppliers

16 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

239 FDF Dossiers, 155 FDA Orange Book, 24 Europe, 17 Canada, 2 Australia, 41 Listed Dossiers

239 FDF Dossiers
155 FDA Orange Book
24 Europe
17 Canada
2 Australia
41 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Evonik, 6 Rochem International Inc, 18 SPI Pharma, 9 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 6 Kirsch Pharma, 1 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 4 CD Formulation, 2 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 67 Coating Systems & Additives, 42 Thickeners and Stabilizers, 39 Direct Compression, 36 Solubilizers, 36 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 33 Granulation, 29 Taste Masking, 28 Parenteral, 24 Topical, 19 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 15 Film Formers & Plasticizers, 14 Rheology Modifiers, 13 Co-Processed Excipients, 10 Emulsifying Agents, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents

77 Fillers, Diluents & Binders
67 Coating Systems & Additives
42 Thickeners and Stabilizers
39 Direct Compression
36 Solubilizers
36 Controlled & Modified Release
34 Disintegrants & Superdisintegrants
33 Granulation
29 Taste Masking
28 Parenteral
24 Topical
19 Chewable & Orodispersible Aids
17 Lubricants & Glidants
15 Film Formers & Plasticizers
14 Rheology Modifiers
13 Co-Processed Excipients
10 Emulsifying Agents
8 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

1 Data Compilation #PharmaFlow
63 News #PharmaBuzz

GLOBAL SALES INFORMATION

43 US Medicaid Prescriptions, 31 Regulatory FDF Prices, 3 Annual Reports

43 US Medicaid Prescriptions
31 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

43 APIs, 42 FDF Dossiers

43 APIs
42 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 6 Health Canada Patents

5 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 16 Others

3 EDQM
16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 92 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 3McNeil Consumer Healthcare, division of Johnson & Johnson Inc.

02 3Merck Canada Inc.

filter Patent Reset all filters

6 All

01 12052679

02 12110313

03 32178277

04 12267503

filter Product Reset all filters

6 All

01 3Famotidine

02 3Famotidine | Calcium Carbonate | Magnesium Hydroxide

filter Dosage Reset all filters

6 All

01 5Tablet (chewable)

02 1Tablet (film coated)

filter Exp Date Reset all filters

6 All

01 12011-08-21

02 12013-11-30

03 32016-06-05

04 12017-09-30

Product Main Page

01

McNeil Consumer Healthcare, division of Jo...

Famotidine, Calcium Carbonate, Magnesium Hydroxide

CPhI Korea

Not Confirmed

McNeil Consumer Healthcare, divisio...

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-30

Date Granted : 2004-10-26

Famotidine, Calcium Carbonate, Magnesium Hydroxide

Brand Name : PEPCID COMPLETE

Patent Number : 2110313

Filing Date : 1993-11-30

Strength per Unit : 10mg/800mg/165mg

Dosage Form : Tablet (chewable)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-30

Date Granted : 2004-10-26

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

McNeil Consumer Healthcare, division of Jo...

Famotidine, Calcium Carbonate, Magnesium Hydroxide

CPhI Korea

Not Confirmed

McNeil Consumer Healthcare, divisio...

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Famotidine, Calcium Carbonate, Magnesium Hydroxide

Brand Name : PEPCID COMPLETE

Patent Number : 2178277

Filing Date : 1996-06-05

Strength per Unit : 10mg/800mg/165mg

Dosage Form : Tablet (chewable)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

McNeil Consumer Healthcare, division of Jo...

Famotidine, Calcium Carbonate, Magnesium Hydroxide

CPhI Korea

Not Confirmed

McNeil Consumer Healthcare, divisio...

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-09-30

Date Granted : 2002-04-30

Famotidine, Calcium Carbonate, Magnesium Hydroxide

Brand Name : PEPCID COMPLETE

Patent Number : 2267503

Filing Date : 1997-09-30

Strength per Unit : 10mg/800mg/165mg

Dosage Form : Tablet (chewable)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-09-30

Date Granted : 2002-04-30

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

Merck Canada Inc.

Famotidine

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-21

Date Granted : 1997-12-02

Brand Name : PEPCID AC

Patent Number : 2052679

Filing Date : 1991-08-21

Strength per Unit : 10 mg

Dosage Form : Tablet (chewable)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-21

Date Granted : 1997-12-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Merck Canada Inc.

Famotidine

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Brand Name : PEPCID AC

Patent Number : 2178277

Filing Date : 1996-06-05

Strength per Unit : 10 mg

Dosage Form : Tablet (film coated)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Merck Canada Inc.

Famotidine

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Brand Name : PEPCID AC

Patent Number : 2178277

Filing Date : 1996-06-05

Strength per Unit : 10 mg

Dosage Form : Tablet (chewable)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-05

Date Granted : 2000-11-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!